AHR and hepatocellular carcinoma: AHR has emerged as a pivotal regulator of hepatic metabolic reprogramming, with roles in the development of metabolic dysfunction-associated fatty liver disease (MAFLD), that increases the risk for progression to end-stage liver disease, and hepatocellular carcinoma (HCC) [19,20].